Log in
Enquire now
‌

US Patent 10959946 Composition and method for vancomycin oral liquid

Patent 10959946 was granted and assigned to Azurity Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Azurity Pharmaceuticals
Azurity Pharmaceuticals
Current Assignee
Azurity Pharmaceuticals
Azurity Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10959946
Date of Patent
March 30, 2021
Patent Application Number
15126059
Date Filed
March 13, 2015
Patent Citations Received
‌
US Patent 11638692 Composition and method for vancomycin oral liquid
0
Patent Primary Examiner
‌
Sarah Alawadi
Patent abstract

The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10959946 Composition and method for vancomycin oral liquid

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.